PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study

Clinical trial NCT07670650 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07670650
Sponsor: University of Florida
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes (T1D)

Start date: 2026-09-01
Primary completion: 2029-03-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.